✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Genexol-PM is an investigational drug.
There have been 18 clinical trials for Genexol-PM. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2009.
The most common disease conditions in clinical trials are Breast Neoplasms, Ovarian Neoplasms, and Carcinoma, Ovarian Epithelial. The leading clinical trial sponsors are Samyang Biopharmaceuticals Corporation, Gachon University Gil Medical Center, and Asan Medical Center.
Recent Clinical Trials for Genexol-PM
|A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib||Gachon University Gil Medical Center||Phase 2|
|Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer||Samyang Biopharmaceuticals Corporation||Phase 1|
|Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas||Samyang Biopharmaceuticals Corporation||Phase 2|